您现在位置：健康网-医药产业 >> 研究报告 >> English reports >> English reports >> 浏览医药行业研究报告
Industry investigation report of China's GCLE
[关键字]： Chinas Medicine Market,report,GCLE,Industry investigation
健康网讯：
Publisher: Beijing Orientbit Technology Co., Ltd.
Format: Adobe PDF
Price: $1,300
Contact: Ms. Wu huifang Mr. Bian Chenghua
Tel.: 86-10-68032463 Fax: 86-10-68052525
E-mail: bianch@healthoo.com wuhf@healthoo.com
Catalog
Summary
1 General situation of China's producers
1.1 All the manufacturers and relative information
1.2 The production capacities of producers
1.3 The actual outputs from 2009 to 2011
2 Export situation
2.1 The ratio of export amount vs. domestic sale amount
2.2 Export amounts、prices、destination countries
3 About domestic market
3.1 Market shares of different producers
3.2 The present market situation of GCLE in China
3.3 Forecast on export and domestic sale
3.4 Recent several years' price and future price
4 The affecting factors
4.1 Affecting factors for production and sale
4.2 Key materials of GCLE
5 Industry trend forecast
Table 2 The outputs of different producers from 2009 to 2012
Table 3 The outputs and export volumes from 2009 to 2011
Table 4 The export volumes of different exporters from 2009 to 2011
Table 5 The export volumes to different countries from 2009 to 2011
Table 6 Destination country and exporters in 2011
Table 8 The ratios of self-use vs. export for main producers
Table 9 Domestic price range from 2009 to 2011
Table 10 Used volumes of materials calculated by 500 ton annual output
Table 11 Domestic price trend of Penicillin G potassium salt from 2009 to 2011
Table 12 Import price trend of 4-Methoxybenzyl alcohol from 2009 to 2011
Graph 2 Domestic market shares of different producers (by volume)
|
||||||||||||||
相关连接
Zhejiang Medicine: The vitamin industry is relatively stable, and the company will expand into the flavor market.
Zhejiang Medicine: The net profit in the third quarter of 2024 was 534 million yuan, up by 1,737.57% year-on-year.
Unveiling the Future Direction of Innovative Medicines in 2024
The Future of Personalized Medicine
With a $10 billion market a clinical shortage, the first "Snoring medicine" is expected to hit the market
Huadong Medicine Liraglutide Injection for Obesity or Overweight Indication Application for Listing
February Market Analysis of Raw Materials for Veterinary Medicines